Clinical aspects of the spondyioarthropathies

American Journal of the Medical Sciences

Volumn 316, Issue 4, 1998, Pages 234-238

  Gladman, Dafna D ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Ankylosing spondylitis; Inflammatory bowel disease; Psoriatic arthritis; Reiter's reactive arthritis; Spondyloarthropathies

Indexed keywords

HLA B27 ANTIGEN; RHEUMATOID FACTOR;

ANKYLOSING SPONDYLITIS; AORTA ROOT; CLINICAL FEATURE; CONFERENCE PAPER; ENTERITIS; FAMILIAL DISEASE; HUMAN; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; REITER SYNDROME; SEROCONVERSION; SPONDYLOARTHROPATHY; DIFFERENTIAL DIAGNOSIS; PATHOPHYSIOLOGY; REVIEW; SPONDYLITIS;

ARTHRITIS, PSORIATIC; DIAGNOSIS, DIFFERENTIAL; HLA-B27 ANTIGEN; HUMANS; REITER SYNDROME; SPONDYLITIS; SPONDYLITIS, ANKYLOSING;

EID: 0031596170     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199810000-00003     Document Type: Conference Paper

References (29)

1. Wright V, Moll JMH. Seronegative Polyarthritis. North Holland Publishing Co: 1976.
2. Gran JT. An epidemiologic survey of the signs and symptoms of ankylosing spondylitis. Clin Rheumatol. 1985;4:161-9.
3. Bennett PH, Burch TA. The epidemiological diagnosis of ankylosing spondylitis. In: Bennet PH, Wood PHN, eds. Proceedings of the 3rd International Symposium of Population Studies of the Rheumatic Diseases. Amsterdam: Exerpta Medica Foundation; 1966:305-13.
4. Resnick D, Niyawama C. Ankylosing spondylitis. In: Resnick D, ed. Diagnosis of Bone and Joint Disorders. 3rd ed. Philadelphia: WB Saunders; 1994:1008-74.
5. Cohen MD, Ginsurg WW. Late onset peripheral joint disease in ankylosing spondylitis. Arthritis Rheum. 1983;26:186-90.
6. Carrett S, Graham D, Little H, Rubenstein J, Rosen P. The natural disease course of ankylosing spondylitis. Arthritis Rheum. 1993;26:186-90.
7. Resnick D. Radiology of seronegative spondyloarthropathies. Clin Orthop Rel Res. 1979;143:38-45.
8. O'Neill TW, Bresnihan B. The heart in ankylosing spondylitis. Ann Rheum Dis. 1992;51:705-6.
9. Rubin LA, Amos CI, Wade JA, et al. Investigating the genetic basis for ankylosing spondylitis: linkage studies with the major histocompatibility complex region. Arthritis Rheum. 1994;37:1212-20.
10. Khan MA, Khan MK. Diagnostic value of HLA-B27 testing in ankylosing spondylitis and Reiter's syndrome. Am J Med. 1982;96:70-6.
11. Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT. Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis: genetic and gender effects. Clin Invest Med. 1993;16:1-7.
12. Kaprove RE, Little AH, Graham DC, Rosen PS. Ankylosing spondylitis survival in men with and without radiotherapy. Arthritis Rheum. 1980;23:57-61.
13. Kraag G, Stokes B, Groh J, Helewa A, Goldsmith CH. The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis: an 8-month followup. J Rheumatol. 1994;21:261-3.
14. Bosi Ferraz M, Tugwell P, Goldsmith CH, et al. Meta-analysis of sulfasalazine in ankylosing spondylitis. J Rheumatol. 1990;17:1482-6.
15. Clegg DO, Reda DJ, Wesman JH, et al. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. Arthritis Rheum. 1996;39:2004-12.
16. Gladman DD. Psoriatic arthritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of Rheumatology. 5th ed. Philadelphia: WB Saunders; 1997:999-1005.
17. Buskila D, Langevitz P, Gladman DD, Urowitz S, Smythe H. Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol. 1992;19:1115-9.
18. Gladman DD, Anhorn KB, Schachter RK, Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol. 1986;13:586-92.
19. Moll JM, Wright V. Familial occurrence of psoriatic arthritis. Ann Rheum Dis. 1973;32:181-201.
20. Nair RP, Henseler T, Jenisch S, et al. Genome scan identifies four susceptibility loci for psoriasis. Am J Hum Genet. 1997;61:4-42.
21. Gladman DD. The natural history of psoriatic arthritis. In: Wright V, Helliwell P, eds. Psoriatic Arthritis (Baillière's Clinical Rheumatology: International Practice and Research). London: Baillières Tindall; 1994;379-94.
22. Gladman DD, Farewell VT, Nadeau C. Clinical indicators of progression in psoriatic arthritis (PSA): multivariate relative risk model. J Rheumatol. 1995;22:675-9.
23. Gladman DD, Farewell VT. The role of HLA antigens as indicators of progression in psoriatic arthritis (PSA): multivariate relative risk model. Arthritis Rheum. 1995;38:845-50.
24. Rahman P, Gladman DD, Cook RJ, Zhu Y, Young G. The use of sulfasalazine in psoriatic arthritis: a clinic experience. J Rheumatol (in press).
25. Arnett FC. Reactive arthritis (Reiter's syndrome) and enteropathic arthritis. In: Klippel JH, ed. Primer on the Rheumatic Diseases. 11th ed. Atlanta: Arthritis Foundation; 1997:184-8.
26. Kettering JM, Towers JD, Rubin DA. The seronegative spondyloarthropathies. Semin Roentgenol. 1996;31:220-8.
27. Butler MJ, Russell AS, Percy JB, et al. A follow-up study of 48 patients with Reiter's syndrome. Am J Med. 1979;67:808-10.
28. Gravallese EM, Kantrowitz G. Arthritic manifestations of inflammatory bowel disease: clinical review. Am J Gastroentrol. 1988;83:703-9.
29. Naom I, Lee J, Ford D, Bowman SJ, et al. Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease. Am J Hum Genet. 1996;59:226-33.